Indian Company Master Data Made Simple
Metropolis Healthcare Limited
Metropolis Healthcare Limited, established in 2000, boasts 25 years of expertise in its field. The company’s Corporate Identification Number is L73100MH2000PLC192798; registration no. 192798. The company operates as company limited by shares. The company’s authorized capital value is ₹63.86 crore. The total paid-up share capital is ₹10.25 crore.
Metropolis Healthcare Limited primarily operates in research and experimental development on natural sciences and engineering (nse). [this class includes systematic creative work in the fields of research and development in natural sciences, m. The company’s registration location is Mumbai. The firm’s incorporation address reads 4th Floor, East Wing, Plot-254 B, Nirlon House, Dr. Annie Besant Road, Worli, Worli Colony, Mumbai, Mumbai, Maharashtra, India, 400030. Metropolis Healthcare Limited holds an active company status. Its PAN is registered as AACCP1414E. As per official records, the company’s LEI is 335800SD5OOGR1D97215. The company’s official contact email is secretarial@metropolisindia.com. The executive leadership listing includes Chemmenkotil Surendran (CEO) and Aditya Vijay Shinde (CFO).
Company Overview
- CIN
- Date of Incorporation
- 10/11/2000
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹63,86,08,030.00
- Paid up Capital
- ₹10,25,34,672.00
- Activity
- Research and experimental development on natural sciences and engineering (NSE). [This class includes systematic creative work in the fields of research and development in natural sciences, m
- secretarial@metropolisindia.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Haryana | 06AACCP1414E1Z1 | Active |
| Karnataka | 29AACCP1414E1ZT | Inactive |
| Maharashtra | 27AACCP1414E1ZX | Inactive |
| Tamil Nadu | 33AACCP1414E1Z4 | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8112L01011 | METROPOLIS HEALTHCARE LIMITED EQ NEW FV RS. 2/-LISTING/TRDG APRVL AWAITED | - | 12/10/2026 | METROPOLS HLTCR/SH VTG | ESVUFN |
| INE112L01020 | METROPOLIS HEALTHCARE LIMITED EQ NEW FV RS. 2/- | - | 12/10/2026 | METROPOLS HLTCR/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹41,503.07L | ₹36,147.08L | ₹33,637.11L | ₹31,091.56L | ₹0.00L |
| Goodwill | ₹66,024.91L | ₹58,988.34L | ₹45,468.37L | ₹45,468.37L | ₹0.00L |
| Gross PPE | ₹61,083.53L | ₹53,648.39L | ₹47,927.38L | ₹43,899.47L | ₹0.00L |
| Inventory | ₹4,549.37L | ₹4,784.07L | ₹3,869.36L | ₹4,459.13L | ₹0.00L |
| Total Debt | ₹23,191.11L | ₹20,412.74L | ₹19,706.45L | ₹26,638.45L | ₹0.00L |
| Common Stock | ₹4,146.57L | ₹1,036.01L | ₹1,024.54L | ₹1,024.21L | ₹0.00L |
| Current Debt | ₹1,873.08L | ₹892.22L | ₹0.00L | ₹5,043.81L | ₹0.00L |
| Share Issued | ₹2,073.28L | ₹2,072.00L | ₹2,049.07L | ₹2,048.43L | ₹0.00L |
| Total Assets | ₹2,13,805.46L | ₹1,86,734.02L | ₹1,55,506.26L | ₹1,50,160.90L | ₹0.00L |
| Capital Stock | ₹4,146.57L | ₹1,036.01L | ₹1,024.54L | ₹1,024.21L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹527.18L | ₹0.00L | ₹2,861.42L | ₹0.00L |
| Current Assets | ₹46,861.21L | ₹34,594.04L | ₹31,582.97L | ₹30,273.44L | ₹0.00L |
| Prepaid Assets | ₹4,957.11L | ₹3,058.56L | ₹2,611.57L | ₹2,573.14L | ₹0.00L |
| Working Capital | ₹13,459.00L | ₹5,160.63L | ₹6,995.55L | ₹3,776.36L | ₹0.00L |
| Invested Capital | ₹1,53,189.14L | ₹1,34,516.61L | ₹1,09,615.55L | ₹1,06,728.46L | ₹0.00L |
| Other Properties | ₹32,623.15L | ₹28,039.67L | ₹25,666.13L | ₹24,758.74L | ₹0.00L |
| Retained Earnings | ₹1,20,297.14L | ₹1,03,137.71L | ₹88,802.33L | ₹78,235.64L | ₹0.00L |
| Common Stock Equity | ₹1,51,316.06L | ₹1,33,097.21L | ₹1,09,615.55L | ₹98,823.23L | ₹0.00L |
| Net Tangible Assets | ₹32,208.10L | ₹24,452.58L | ₹25,512.73L | ₹15,869.84L | ₹0.00L |
| Tangible Book Value | ₹32,208.10L | ₹24,452.58L | ₹25,512.73L | ₹15,869.84L | ₹0.00L |
| Current Liabilities | ₹33,402.21L | ₹29,433.41L | ₹24,587.42L | ₹26,497.08L | ₹0.00L |
| Long Term Provisions | ₹3,415.76L | ₹2,669.72L | ₹1,579.52L | ₹1,302.02L | ₹0.00L |
| Stockholders Equity | ₹1,51,316.06L | ₹1,33,097.21L | ₹1,09,615.55L | ₹98,823.23L | ₹0.00L |
| Other Equity Interest | ₹1,092.16L | ₹792.08L | ₹772.95L | ₹734.74L | ₹0.00L |
| Total Capitalization | ₹1,51,316.06L | ₹1,33,624.39L | ₹1,09,615.55L | ₹1,01,684.65L | ₹0.00L |
| Ordinary Shares Number | ₹2,073.28L | ₹2,072.00L | ₹2,049.07L | ₹2,048.43L | ₹0.00L |
| Other Intangible Assets | ₹53,083.05L | ₹49,656.29L | ₹38,634.45L | ₹37,485.02L | ₹0.00L |
| Other Non Current Assets | -₹0.02L | -₹0.03L | -₹0.01L | -₹0.00L | ₹0.00L |
| Total Non Current Assets | ₹1,66,944.25L | ₹1,52,139.98L | ₹1,23,923.29L | ₹1,19,887.46L | ₹0.00L |
| Cash And Cash Equivalents | ₹5,478.36L | ₹3,947.57L | ₹6,261.83L | ₹6,883.32L | ₹0.00L |
| Construction In Progress | ₹501.67L | ₹95.40L | ₹33.70L | ₹27.03L | ₹0.00L |
| Accumulated Depreciation | -₹19,580.46L | -₹17,501.31L | -₹14,290.27L | -₹12,807.91L | ₹0.00L |
| Additional Paid In Capital | ₹22,016.51L | ₹24,619.11L | ₹15,658.09L | ₹15,658.08L | ₹0.00L |
| Other Short Term Investments | ₹14,818.08L | ₹7,878.41L | ₹6,166.90L | ₹2,523.67L | ₹0.00L |
| Machinery Furniture Equipment | ₹11,734.90L | ₹10,758.01L | ₹8,873.11L | ₹7,947.99L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹1,19,107.96L | ₹1,08,644.63L | ₹84,102.82L | ₹82,953.39L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,52,455.50L | ₹1,33,463.93L | ₹1,09,927.48L | ₹99,071.08L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹61,349.96L | ₹53,270.09L | ₹45,578.78L | ₹51,089.82L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹9,364.56L | ₹9,206.95L | ₹7,799.67L | ₹11,226.90L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹13,826.55L | ₹11,205.79L | ₹11,906.78L | ₹15,411.55L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹20,296.44L | ₹11,825.98L | ₹12,428.73L | ₹9,406.99L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹27,947.75L | ₹23,836.68L | ₹20,991.36L | ₹24,592.74L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L | ₹0.00L |
| Free Cash Flow | ₹29,951.17L | ₹19,413.45L | ₹20,030.90L | ₹19,445.63L | ₹0.00L |
| Changes In Cash | ₹1,227.56L | -₹2,494.34L | -₹654.02L | ₹155.54L | ₹0.00L |
| End Cash Position | ₹5,478.36L | ₹3,947.56L | ₹6,261.83L | ₹6,883.32L | ₹0.00L |
| Financing Cash Flow | -₹11,529.48L | -₹8,663.38L | -₹18,119.86L | -₹29,232.88L | ₹0.00L |
| Investing Cash Flow | -₹22,312.51L | -₹20,105.56L | -₹8,941.16L | ₹4,679.44L | ₹0.00L |
| Operating Cash Flow | ₹35,069.55L | ₹26,274.60L | ₹26,407.00L | ₹24,708.98L | ₹0.00L |
| Capital Expenditure | -₹5,118.38L | -₹6,861.15L | -₹6,376.10L | -₹5,263.35L | ₹0.00L |
| Beginning Cash Position | ₹3,947.56L | ₹6,261.83L | ₹6,883.32L | ₹6,598.04L | ₹0.00L |
| Issuance Of Capital Stock | ₹0.65L | ₹1.02L | ₹0.34L | ₹18.36L | ₹0.00L |
| Other Cash Adjustment Inside Changein Cash | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹56.95L | ₹82.05L | -₹50.87L | ₹0.00L | ₹252.92L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹28,371.94L | ₹20,942.76L | ₹19,722.47L | ₹21,430.49L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹41,744.09L | ₹31,810.87L | ₹29,169.25L | ₹30,352.05L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹1,29,061.56L | ₹1,04,780.13L | ₹94,698.57L | ₹88,452.03L |
| Pretax Income | ₹25,917.56L | ₹19,085.29L | ₹17,468.89L | ₹18,750.34L |
| Tax Provision | ₹6,799.36L | ₹4,533.90L | ₹4,623.33L | ₹4,410.94L |
| Total Revenue | ₹1,64,584.59L | ₹1,33,120.28L | ₹1,20,770.88L | ₹1,14,821.02L |
| Cost Of Revenue | ₹35,523.03L | ₹28,340.15L | ₹26,072.31L | ₹26,368.99L |
| Total Expenses | ₹1,34,756.75L | ₹1,12,529.31L | ₹1,00,431.05L | ₹93,938.99L |
| Interest Income | ₹350.47L | ₹350.62L | ₹326.25L | ₹570.78L |
| Interest Expense | ₹2,454.38L | ₹1,857.47L | ₹2,253.58L | ₹2,680.15L |
| Operating Income | ₹29,827.84L | ₹20,590.97L | ₹20,339.83L | ₹20,882.03L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹44,388.13L | ₹31,164.37L | ₹29,057.30L | ₹30,303.36L |
| Normalized Income | ₹20,952.13L | ₹14,003.91L | ₹12,699.30L | ₹14,251.02L |
| Operating Expense | ₹99,233.72L | ₹84,189.16L | ₹74,358.74L | ₹67,570.00L |
| Operating Revenue | ₹1,64,584.59L | ₹1,33,120.28L | ₹1,20,770.88L | ₹1,14,821.02L |
| Net Interest Income | -₹2,539.80L | -₹2,038.07L | -₹2,462.90L | -₹2,614.27L |
| Total Unusual Items | -₹2,644.04L | ₹646.50L | ₹111.95L | ₹48.69L |
| Basic Average Shares | ₹2,067.48L | ₹2,067.48L | ₹2,048.79L | ₹2,047.86L |
| Diluted Average Shares | ₹2,067.48L | ₹2,069.88L | ₹2,055.78L | ₹2,054.80L |
| Total Other Finance Cost | ₹435.89L | ₹531.22L | ₹535.57L | ₹504.90L |
| Other Operating Expenses | ₹12,508.66L | ₹10,388.42L | ₹10,193.96L | ₹8,026.78L |
| Reconciled Depreciation | ₹13,372.15L | ₹10,868.11L | ₹9,446.78L | ₹8,921.56L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹35,523.03L | ₹28,340.15L | ₹26,072.31L | ₹26,368.99L |
| Rent Expense Supplemental | ₹15,276.65L | ₹12,811.89L | ₹10,525.94L | ₹9,409.99L |
| Tax Effect Of Unusual Items | -₹693.65L | ₹153.58L | ₹29.63L | ₹11.45L |
| Interest Income Non Operating | ₹350.47L | ₹350.62L | ₹326.25L | ₹570.78L |
| Selling And Marketing Expense | ₹4,412.93L | ₹3,794.81L | ₹3,277.38L | ₹2,615.55L |
| Interest Expense Non Operating | ₹2,454.38L | ₹1,857.47L | ₹2,253.58L | ₹2,680.15L |
| Net Income Common Stockholders | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L |
| Net Income Continuous Operations | ₹19,118.20L | ₹14,551.39L | ₹12,845.56L | ₹14,339.40L |
| Diluted NIAvailto Com Stockholders | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L |
| General And Administrative Expense | ₹15,807.80L | ₹14,822.65L | ₹13,275.56L | ₹13,243.85L |
| Selling General And Administration | ₹20,220.73L | ₹18,617.46L | ₹16,552.94L | ₹15,859.40L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹2,644.04L | ₹646.50L | ₹111.95L | ₹48.69L |
| Net Non Operating Interest Income Expense | -₹2,539.80L | -₹2,038.07L | -₹2,462.90L | -₹2,614.27L |
| Net Income Including Noncontrolling Interests | ₹19,118.20L | ₹14,551.39L | ₹12,845.56L | ₹14,339.40L |
| Net Income From Continuing And Discontinued Operation | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L |
| Net Income From Continuing Operation Net Minority Interest | ₹19,001.74L | ₹14,496.83L | ₹12,781.62L | ₹14,288.26L |
Company Performance (FY23–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 17/08/2005 | Sushil Kanubhai Shah | 00179918 | Director | View other directorships |
| 06/05/2008 | Ameera Sushil Shah | 00208095 | Whole-time director | View other directorships |
| 29/05/2012 | Milind Shripad Sarwate | 00109854 | Director | View other directorships |
| 07/09/2018 | Vivek Gambhir | 06527810 | Director | View other directorships |
| 07/09/2018 | Sanjay Bhatnagar | 00867848 | Director | View other directorships |
| 14/05/2020 | Anita Ramachandran | 00118188 | Director | View other directorships |
| 27/05/2021 | Hemant Sachdev | 01635195 | Director | View other directorships |
| 02/01/2023 | Chemmenkotil Surendran | *****8393N | CEO | |
| 21/08/2023 | Subramanian Ranganathan | 00125493 | Director | View other directorships |
| 03/02/2024 | Kamlesh Chandrashekhar Kulkarni | *****5533E | Company Secretary | |
| 22/05/2024 | Aparna Chetan Rajadhyaksha | 10596037 | Director | View other directorships |
| 11/11/2024 | Aditya Vijay Shinde | *****2750J | CFO |
Business Network
Directors 12
- Ameera Sushil ShahWhole-time director
- Aparna Chetan RajadhyakshaDirector
- Subramanian RanganathanDirector
- Hemant SachdevDirector
- Anita RamachandranDirector
- Sanjay BhatnagarDirector
- Vivek GambhirDirector
- Milind Shripad SarwateDirector
- Sushil Kanubhai ShahDirector
- Aditya Vijay ShindeCFO
- Kamlesh Chandrashekhar KulkarniCompany Secretary
- Chemmenkotil SurendranCEO
Latest Documents
| Date | Title | Size |
|---|---|---|
| 18/10/2024 | Form MGT-7-18102024_signed | - |
| 20/09/2024 | Form AOC-4(XBRL)-20092024_signed | - |
| 28/03/2024 | Form Addendum to AOC-4 CSR-28032024_signed | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Cfc Laboratories Limited | L73100DL1985PLC022747 | 458-466, Gali No.8, Shambunath Compound Friends Colony, Industrial Area, New Delhi, Delhi, India, 110065 |
| Gsm Institute Of Medical And Technologic Al Sciences Limited | L73100AP2004PLC044380 | H.no.12-234-1, Near Tagore Vidya Niketan, Shareen Nagar, Kurnool-2 Shareen Nagar, Kurnool-2 Ap 000000 In |
| Infollion Research Services Limited | L73100HR2009PLC126450 | 5th Floor, Tower C, Unitech Cyber Park, Sector 39, Gurugram, Gurgaon, Gurgaon, Sadar Bazar, Haryana, India, 122001 |
| Regal Enterprises Ltd | L73100DL1989PLC269075 | Shop No G-2 Plot No 5, Kohli Plaza Block-cu Market, Pitampura, Maurya Enclave, North West Delhi, Delhi, Delhi, India, 110034 |
| Sun Pharma Advanced Research Company Limited | L73100GJ2006PLC047837 | Plot No. 5 & 6/1, Savli G.i.d.c. Estate, Savli – Vadodara Highway, Vadodara, Manjusar, Gujarat, India, 391775 |
Address
Frequently Asked Questions
The current board member of Metropolis Healthcare Limited are:
- Anita Ramachandran
- Vivek Gambhir
- Milind Shripad Sarwate
- Ameera Sushil Shah
- Sushil Kanubhai Shah
- Hemant Sachdev
- Sanjay Bhatnagar
- Aparna Chetan Rajadhyaksha
- Subramanian Ranganathan